UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): December 29, 2010
SOURCEFIRE, INC.
(Exact Name of Registrant as Specified in its Charter)
|
|
|
|
|
Delaware
(State or Other Jurisdiction
of Incorporation)
|
|
1-33350
(Commission
File Number)
|
|
52-2289365
(I.R.S. Employer
Identification No.) |
|
|
|
9770 Patuxent Woods Drive, Columbia, MD
(Address of Principal Executive Offices)
|
|
21046
(Zip code) |
Registrants telephone number, including area code: (410) 290-1616
N/A
(Former Name or Former Address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
|
|
|
o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 1.01. Entry into a Material Definitive Agreement.
On December 29, 2010, Sourcefire, Inc. (the Company) entered into a definitive Agreement and
Plan of Merger (the Merger Agreement) with Immunet Corporation, a California corporation
(Immunet), Cloud Acquisition Corporation (Merger Sub), a wholly-owned subsidiary of the
Company, and certain shareholders of Immunet. Pursuant to the Merger Agreement, on December 30,
2010, Merger Sub merged with and into Immunet, with Immunet as the surviving company and becoming a
wholly-owned subsidiary of the Company (the Merger).
Immunet is a provider of advanced cloud-based anti-malware technologies.
The Company agreed to acquire Immunet for an aggregate amount in cash up to $21 million
(subject to later adjustment based on final determination of net working capital) (the Merger
Consideration). The Merger Consideration includes $17 million paid at closing and up to $4
million payable to the holders of Immunets Common Stock and outstanding options and warrants to
acquire Immunets Common Stock upon the achievement of certain post-closing milestones related to
Immunets products. Under the terms of the Merger Agreement, all of Immunets outstanding Common
Stock and Preferred Stock, as well as outstanding warrants to acquire Immunets Common Stock and
Preferred Stock and outstanding, unexercised options to acquire Immunets Common Stock, were
cancelled and converted into the right to receive an applicable portion of the Merger
Consideration.
The Merger Agreement contains customary representations, warranties and covenants. Pursuant
to the Merger Agreement, Immunets shareholders will indemnify the Company, subject to certain
limitations, for losses arising out of breaches of representations, warranties and covenants in the
Merger Agreement, as well as certain other indemnification items specified in the Merger Agreement.
Immunets Board of Directors unanimously adopted the Merger Agreement and approved the Merger
and recommended adoption of the Merger Agreement and approval of the Merger by Immunets
shareholders. A majority of Immunets stockholders, in the form of a written consent, have
approved the adoption of the Merger Agreement and the Merger.
The foregoing is a summary description of certain terms of the Merger Agreement, does not
purport to be complete, and is qualified in its entirety by reference to the full text of the
Merger Agreement, which will be filed as an exhibit to Sourcefires Form 10-K for the year ending
December 31, 2010.
Item 8.01. Other Events.
On January 5, 2011, the Company issued a press release announcing the closing of its
acquisition of Immunet. The full text of the press release is attached to this Current Report on
Form 8-K as Exhibit 99.1 and incorporated herein by reference. The Company also announced in the
press release a conference call to be held at 5:00 p.m. today to discuss the Merger, the Companys
preliminary fourth quarter 2010 results and its initial 2011 outlook. The text of the Companys
discussion of its preliminary fourth quarter 2010 results is attached to this Current
Report on Form 8-K as Exhibit 99.2. Presentation slides to be discussed during the conference call
are attached to this Current Report on Form 8-K as Exhibit 99.3.
Forward-Looking Statements
The statements in this Form 8-K and the exhibits that are not historical facts are
forward-looking statements (as such term is defined in the Private Securities Litigation Reform
Act of 1995) that involve risks and uncertainties. Management cautions the reader that these
forward-looking statements are only predictions and are subject to a number of both known and
unknown risks and uncertainties, and actual results, performance, and/or achievements of
Sourcefire, Inc. may differ materially from the future results, performance, and/or achievements
expressed or implied by these forward-looking statements as a result of a number of factors. These
factors include, without limitation, the risks that Sourcefire, Inc. will not be able to
successfully integrate the acquisition into its business or that it will not otherwise achieve the
anticipated benefits of the transaction, and also include, without limitation, those risks and
uncertainties described from time to time in the reports filed by Sourcefire, Inc. with the U.S.
Securities and Exchange Commission. Sourcefire, Inc. undertakes no obligation to update any
forward-looking statements.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
|
|
|
99.1
|
|
Press release dated January 5, 2011, Sourcefire Announces Acquisition of Immunet |
|
|
|
99.2
|
|
Text of January 5, 2011 discussion of Sourcefire preliminary fourth quarter 2010 results |
|
|
|
99.3
|
|
Presentation slides dated January 5, 2011 |